BioCentury
ARTICLE | Clinical News

Amevive alefacept regulatory update

May 10, 2004 7:00 AM UTC

BIIB said Israel approved Amevive to treat adults with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy. Separately, BIIB said Swissmedic issued a positive opinion letter for Amevive, and that the company is in the final stages of negotiating the labeled indication. ...